News

BLMs4BU Consortium Meeting in Benin: sharing the progress of the clinical trial and exchange of experiences in the team

On February 20-21, 2025, around 50-60 representatives from various international organizations, clinical staff, and researchers gathered in Benin to strengthen collaboration within the BLMs4BU Consortium, dedicated to the research and improvement of Buruli ulcer treatment.

The BLMs4BU consortium presents an update on the clinical trial activities to the 3rd International Mycobacterium ulcerans Conference

The BLMs4BU consortium showcased cutting-edge research and advancements in Buruli ulcer (BU) treatment.

July highlights from the BLMs4BU project: We actively participated in the skin NTD-LABNET meeting in Madrid and launched a new sub-study in Côte d’Ivoire to explore Buruli ulcer patients’ journey and access barriers

Isra Cruz, member of the WHO Diagnostic Technical Advisory Group for NTDs and lead data manager of the BLMs4BU Consortium, hosted at the Instituto de Salud Carlos III (Madrid, Spain) a new meeting of the Skin NTD-LABNET (8-10 July).

Shedding light on the current and future on Buruli Ulcer and Leprosy treatment at the European Congress on Tropical Medicine and International Health, 2023

The European Congress on Tropical Medicine and International Health (ECTMIH) was held in Utrecht, Netherlands, on 20-23 November 2023, with more than 1000 attendants from all over the world.

The BLMs4BU Consortium contributes to the goals of the network of Buruli ulcer PCR laboratories (BU-LABNET) in the WHO African Region – Fifth Annual BU-LABNET Meeting

The BLMs4BU Consortium contributes to the mission of BU-LABNET by strengthening the laboratory capacity on PCR BU diagnosis in the WHO African region, as well as sharing knowledge and experiences between the member laboratories together with the BU National Programmes of these countries, striving to improve the quality of BU diagnosis.

Mid-term recruitment milestone achieve by the BLMs4BU Phase II project in Benin

Another milestone has been achieved by the BLMs4BU Consortium. The Phase II trial carried out in Benin has enrolled half of the number of patients needed for the study.

Categories

BLMs4BU Consortium at the 2nd WHO Global Meeting on Neglected Tropical Diseases

BLMs4BU Consortium Meeting in Benin: sharing the progress of the clinical trial and exchange of experiences in the team

The BLMs4BU consortium presents an update on the clinical trial activities to the 3rd International Mycobacterium ulcerans Conference

July highlights from the BLMs4BU project: We actively participated in the skin NTD-LABNET meeting in Madrid and launched a new sub-study in Côte d’Ivoire to explore Buruli ulcer patients’ journey and access barriers

Shedding light on the current and future on Buruli Ulcer and Leprosy treatment at the European Congress on Tropical Medicine and International Health, 2023

The BLMs4BU Consortium contributes to the goals of the network of Buruli ulcer PCR laboratories (BU-LABNET) in the WHO African Region – Fifth Annual BU-LABNET Meeting

Mid-term recruitment milestone achieve by the BLMs4BU Phase II project in Benin

Phase III du projet BLMs4BU : Trois mois après le lancement de l’étude au Togo et un mois après en Côte d’Ivoire, six patients sont déjà inclus !

BLMs4BU project presented at the First WHO Global Meeting on Skin NTDs

We will brief you on the latest developments